Asymchem Laboratories (Tianjin) Co., Ltd. (6821.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In HKD
Address
No. 71, Seventh Avenue
Tianjin, TI 300457
China
Phone
+86 22 6625 2888
Website
Sector
Healthcare
Industry
Biotechnology
Employees
10617
First IPO Date
December 10, 2021
| Name | Title | Pay | Year Born |
| Rui Yang | Co-CEO & Executive Director | 6.43M | 1977 |
| Hao Hong | Founder, Chairman & Chief Executive Officer | 8.57M | 1956 |
| Liang Hong | Executive Vice President & Executive Director | 3.59M | 1974 |
| Da Zhang | Chief Financial Officer, Chief Operating Officer, Senior Vice President & Executive Director | 5.91M | 1981 |
| Mo Huang | Accounting Supervisor | 0 | N/A |
| Yan Zhou | Senior Vice President of Quality Management | 0 | 1979 |
| Xiangke Xu | Senior Vice President and Board Secretary of Public Affairs & Regulatory Affairs & Legal Affairs | 0 | 1979 |
| Elut Hsu | Senior Vice President of U.S. Headquarters Operations & Business Development | 0 | N/A |
| Chen Yi Cheng | Chief Technology Officer of the Small-Molecule Sector | 0 | 1964 |
| Chaoyong Chen | Executive Vice President of Manufacturing & Tech Transfer | 0 | 1982 |
| Ching Kit Cheng | Joint Company Secretary | 0 | 1989 |
| Jiang Yingwei | Executive Vice President of Human Resources & Administration | 0 | 1977 |
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a Contract Development and Manufacturing Organization (CDMO), offering its services to clients across Mainland China and internationally. The company delivers extensive drug research, development, and manufacturing solutions specifically tailored for pharmaceutical and biotechnology enterprises. Their offerings are comprehensive, covering the entire lifecycle from early clinical stages through to full commercialization, including R&D and cGMP compliant production of advanced intermediates, active pharmaceutical ingredients (APIs), and finished formulations, alongside clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the sale and distribution of medicinal products, and active participation in pharmaceutical science and technology innovation. The company was founded in 1999 and maintains its headquarters in Tianjin, China.